ARKG

ARK$45.70+0.33 (+0.73%)
AUM $1.56BER 0.75%NAV $45.35Holdings 10

Price Chart

Key Statistics

Previous Close

$45.38

Day Range

$45.29$46.25

52-Week Range

$24.82$50.06

Avg Volume

3.6M

Dividend Yield

—

Expense Ratio

0.75%

AUM

$1.56B

Shares Outstanding

34.9M

ETF Grades

?

Sector Breakdown

SectorWeight %
Healthcare97.11%
Technology2.37%
Cash & Others0.52%

Country Allocation

CountryWeight %
United States88.57%
Switzerland5.98%
United Kingdom3.11%
Other2.33%

Fund Information

Issuer
ARK
Category
Healthcare
Inception Date
Oct 30, 2014
Exchange
BATS
Description
ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors that are relevant to the Fund’s investment theme of the genomics revolution.

Similar ETFs

SymbolNameAUM
SCHDSchwab U.S. Dividend Equity ETF$110.53B
IWMiShares Russell 2000 ETF$77.55B
XLVState Street Health Care Select Sector SPDR ETF$43.25B
VHTVanguard Health Care ETF$20.90B
VTWOVanguard Russell 2000 ETF$17.40B

The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund issued by ARK that launched on Oct 30, 2014. It currently manages $1.56B in assets under management. The fund charges an expense ratio of 0.75%. The fund holds 10 securities in its portfolio. It falls under the Healthcare category.

Top 10 holdings represent 59.3% of the fund

RankSymbolNameWeight %SharesMarket Value
1TXG10X GENOMICS INC-CLASS A10.26%2,814,382$186.8M
2TWSTTWIST BIOSCIENCE CORP8.33%1,196,520$151.8M
3TEMTEMPUS AI INC-CL A7.67%2,376,903$139.6M
4CRSPCRISPR THERAPEUTICS AG5.92%2,064,555$107.9M
5PSNLPERSONALIS INC5.86%6,534,895$106.7M
6ABSIABSCI CORP4.63%10,236,901$84.4M
7GHGUARDANT HEALTH INC4.43%507,266$80.7M
8NTRANATERA INC4.28%238,957$77.9M
9CDNACAREDX INC4.00%1,455,894$72.8M
10ILMNILLUMINA INC3.96%358,021$72.1M
11LLYELI LILLY & CO3.90%63,190$71.0M
12CMPSCOMPASS PATHWAYS PLC3.47%4,441,751$63.2M
13BEAMBEAM THERAPEUTICS INC3.26%2,437,879$59.4M
14NRIXNURIX THERAPEUTICS INC2.37%1,673,718$43.2M
15RXRXRECURSION PHARMACEUTICALS-A2.35%13,571,307$42.9M

Detailed Returns

PeriodReturnETF
1D
+0.73%
1W
-3.35%
1M
+2.80%
3M
+29.80%
6M
+71.60%
YTD
+56.13%
1Y
+77.97%
3Y
+45.42%
5Y
-44.08%

Moving Averages

20-Day MA

$47.01

Below 20-Day MA
50-Day MA

$43.31

Above 50-Day MA
200-Day MA

$33.76

Above 200-Day MA

Price with Moving Averages

Support & Resistance

52-Week High

$50.06

Current Price

$45.70

52-Week Low

$24.82

$24.82$50.06

Current Yield

—

Annual Dividend

$2.3445

Frequency

1x/year

Last Ex-Date

Dec 29, 2021

Dividend History

Ex-DateAmountPay Date
Dec 29, 2021$0.3824Dec 31, 2021
Dec 29, 2021$0.3820Dec 31, 2021
Dec 29, 2020$0.7901Dec 31, 2020
Dec 29, 2020$0.7900Dec 31, 2020
Dec 27, 2019$1.0540Dec 31, 2019
Dec 27, 2019$1.0539Dec 31, 2019
Dec 27, 2018$0.4660Dec 31, 2018
Dec 27, 2018$0.2700Dec 31, 2018
Dec 27, 2018$0.1963Dec 31, 2018
Dec 27, 2017$0.3280Dec 29, 2017
Dec 27, 2017$0.1927Dec 29, 2017
Dec 27, 2017$0.1350Dec 29, 2017

Dividend Payments Over Time

Category Comparison

MetricARKGHealthcare(254 ETFs)Innovation(5 ETFs)
Fund Info
Expense Ratio0.75%0.62%0.75%
AUM$1.56B$1.73B$2.26B
Dividend Yield—3.97%0.72%
Avg Volume3.6M364.4K1.6M
Holdings1016016
Performance
1-Month Return+4.86%-2.86%+1.30%
6-Month Return+48.36%+7.23%+14.04%
YTD Return+57.27%+10.59%+14.34%
1-Year Return—+8.50%+1.06%

Compare with Another ETF

Search for an ETF to compare with ARKG:

FREE DOWNLOAD

The Beginner's Guide to ETFs

20 pages. Zero fluff. Everything you need to start investing in ETFs.

No spam. Unsubscribe anytime.